SciELO - Scientific Electronic Library Online

 
 número27Epidemiología y factores de riesgo de enfermedad invasiva neumocócica en pediatría: Estudio descriptivo, postvacunalAplicación de la lógica difusa en el proceso de evaluación en Matemática índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista de Ciencia y Tecnología

versão On-line ISSN 1851-7587

Resumo

REYES GUZMAN, Edwin Alfredo; VEGA CASTRO, Nohora Angélica  e  REYES MONTANO, Edgar Antonio. Diseño de péptidos inhibidores de interacciones de la subunidad GluN2B del receptor NMDA en isquemia. Rev. cienc. tecnol. [online]. 2017, n.27, pp.11-22. ISSN 1851-7587.

The NMDA receptor is the major subtype of glutamate receptors involved in physiological processes such as neuronal development, synaptic plasticity, learning and memory and numerous pathological conditions such as ischemic damage, chronic pain, psychosis, and other neurodegenerative disorders. It has been suggested regulation by phosphorylation as a mechanism altering the relative permeability of the NMDAR to Ca2 + during ischemia. This paper presents a series of peptides that were designed based on GluN2B subunit interactions with proteins DAPK1, SRC and D2R related to the effects generated after an ischemic event. The identification of binding sites among these molecules and GluN2B allowed to make an in silico design of peptides that can eventually block these interactions and reduce the harmful effects of diseases such as ischemia. Our results demonstrate that the rational design of peptides is a good strategy to generate new therapeutic agents.

Palavras-chave : NMDA; Ischemia; Design; Peptides; In silico.

        · resumo em Português | Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons